By H. Asao, MD, PhD, and K. Oji, MD, PhD. Price, $7.50. Charles C Thomas, Publisher, 301-327 E Lawrence Ave, Springfield, Ill 62703, 1968.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This little monograph deserves little comment. It is one of a series on "Living Chemistry" (whatever that means), and purports to describe the chemical changes in diseases affecting brain and liver. This comes down to a discussion of hepatic encephalopathy and its clinical, pathological, chemical, and therapeutic aspects. The most striking thing noticed on examining this overpriced volume is the poor spelling, grammar, and word utilization by the authors. Certainly an attempt could have been made to edit the text; instead it emerges as largely incomprehensible. There is insufficient data to justify most of the authors' conclusions. For example, they describe two varieties of hepatic encephalopathy: the type described by Inose and a pseudoulegyric type. They fail to convince the reader that there is any significant difference between the two, clinically or pathologically. A section on therapy fails to include exchange transfusion. Many references are cited, mostly from Japanese sources,
Biehl JP. Hepatocerebral Degeneration. Arch Intern Med. 1969;123(5):605. doi:10.1001/archinte.1969.00300150123029
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: